Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy
Clinical trial NCT05638776 · COMPLETED
Trial details
- NCT number
- NCT05638776
- Sponsor
- Regend Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2025-07-09
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.